Viewing Study NCT00634634


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-28 @ 12:03 AM
Study NCT ID: NCT00634634
Status: COMPLETED
Last Update Posted: 2023-11-09
First Post: 2008-03-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Sponsor: Rutgers, The State University of New Jersey
Organization: